Federal contract award
75N93023F00001
EPCTU
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93022D00017 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $2.8M |
| Current contract value | $2.8M |
| Potential contract value / ceiling | $2.8M |
| Start date | Jun 29, 2023 |
| Current end date | Jan 31, 2026 |
| Potential end date | Jan 31, 2026 |
| Latest award activity | Nov 25, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 25, 2025 | P00005 | $0 | EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI |
| Aug 11, 2025 | P00004 | $0 | EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI |
| Aug 7, 2025 | P00003 | $0 | EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI |
| Aug 28, 2024 | P00002 | $0 | EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI |
| Jul 20, 2023 | P00001 | $2.7M | EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI |
| Jun 29, 2023 | 0 | $104.3K | EPCTU |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.